Twist Bioscience TWST Cash Flow Statement (2017-2026)

NASDAQ TWST
$111.62 -4.73 (-4.07%)
At close: Nov 19, 2026 · 4:00 PM EST
Reported Financials

Twist Bioscience Quarterly Cash Flow Statement

Periods 36 quarters
Latest Sep 2026
Industry Template General

Twist Bioscience reported cash from operations of -$0.17M and free cash flow of $80.03M for the quarter ended Sep 2026, up 98.5% year over year. This cash flow statement covers 36 quarters of results from Dec 2017 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-45.56M-60.67M-60.52M-51.15M-41.82M-59.16M-57.40M-46.24M-43.01M-45.50M-85.60M-34.63M-31.60M-39.33M20.40M-27.17M-30.51M-44.02M-35.10M-20.60M
Depreciation and DepletionDep. & Depletion
3.90M5.70M6.90M7.30M6.90M7.00M7.00M6.40M6.10M6.10M5.80M5.70M5.90M6.10M6.50M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.00M
Depreciation & Amortization (CF)Dep. & Amort.
3.15M3.97M4.44M4.95M5.29M7.03M8.49M8.50M8.17M8.30M8.30M6.66M6.38M6.40M6.07M6.00M6.19M6.41M6.78M7.10M
Share-based CompensationStock Comp.
18.11M22.47M20.04M19.05M-2.33M10.26M10.60M11.75M11.02M13.82M13.73M12.35M11.99M20.33M16.06M16.08M13.27M18.94M18.18M19.47M
Deferred Taxes
-10.55M-0.50M-0.13M
Gains from Sales and DivestituresGains Divest
-3.17M48.85M
Gains from Investment SecuritiesGains Investment
Asset Writedowns and ImpairmentWritedown
1.17M0.44M0.99M17.53M0.25M0.33M0.45M1.53M0.25M0.26M0.14M0.29M-0.02M
Other non-cash itemsOther Non-Cash
0.40M0.29M-0.68M-0.02M0.29M0.29M-0.61M-5.76M0.31M0.48M-0.33M0.53M-0.02M0.83M1.15M0.24M-0.34M-0.50M0.16M0.94M
Change in Working Capital
Change in ReceivablesChange Receivables
2.03M1.81M6.44M-0.66M4.10M3.95M-5.54M1.81M-8.06M0.66M-4.00M2.95M4.54M10.72M-0.09M7.21M-6.83M14.24M1.09M-22.30M
Change in InventoryChange Inventory
8.44M4.35M-1.55M-3.70M5.28M-4.68M-3.56M-4.29M-1.20M-0.49M-1.89M-4.41M-0.56M-2.66M5.08M2.37M4.62M0.59M1.65M-24.95M
Change in Account PayablesChange Payables
-0.01M-0.76M1.23M6.92M3.28M-7.49M-0.22M1.92M-4.21M-1.52M-1.20M-4.88M5.71M0.71M3.19M-0.28M1.47M0.07M3.04M9.35M
Change in Accrued ExpensesChange Accrued Exp.
-3.62M5.51M3.63M-0.67M-3.72M6.61M-1.62M1.30M-5.08M8.94M2.07M1.94M-11.85M3.19M17.57M-3.16M-12.44M35.23M2.86M-18.60M
Change in Other Operating AssetsOther Assets Change
-3.14M0.67M-1.63M-0.63M0.68M-0.29M0.50M1.91M0.82M-0.71M-0.40M-0.53M0.61M-0.87M2.69M2.86M7.51M11.77M-0.02M-20.70M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.03M0.87M2.12M-10.38M0.13M-0.53M2.20M-1.91M-1.53M-1.06M0.73M-0.47M-0.60M1.94M4.14M1.14M1.32M
Other Working Capital ChangesOther WC Changes
3.11M0.19M3.75M-9.75M-0.55M-0.24M1.70M-3.81M-2.34M-0.35M1.13M0.06M-1.21M2.80M1.46M-1.73M-6.19M-11.77M0.02M20.70M
Other Operating Activities (as filed)
-0.02M0.83M1.15M-0.34M-0.50M0.16M
Cash from OperationsCash from Ops.
-46.65M-42.34M-34.13M-1.27M-54.07M-44.29M-23.41M-20.70M-22.97M-19.42M-6.38M-15.32M-21.43M-12.99M-1.40M-11.81M-24.81M-17.56M1.12M-0.17M
Investing Activities
Capital ExpendituresCapex
12.78M31.97M40.64M16.46M11.82M9.05M4.51M2.39M1.51M0.60M0.97M2.00M2.27M4.14M9.17M12.43M9.97M12.89M9.76M-80.21M
Sales of Property, Plant and EquipmentPP&E (Sale)
Change in Property, Plant and EquipmentChange in PP&E
-12.78M-31.97M-40.64M-16.46M-11.82M-9.05M-4.51M-2.39M-1.51M-0.60M-0.97M-2.00M-2.27M-4.14M-9.17M-12.43M-9.97M-12.89M-9.76M80.21M
Acquisitions
8.16M
Change in IntangiblesChange Intangibless
-7.05M
Net of Acquisitions & DivestmentsNet Acquisitions
-8.16M
Purchase of InvestmentsInvestments Purchased
-86.37M
Sale and Maturity of InvestmentsInvestments Sold
11.00M
Cash from Investing ActivitiesCash from Investing
-20.25M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
-3.71M15.00M
Long-Term Debt RepaymentsLT Debt Repayment
Net Long-Term Debt Issued (Repaid)Net LT Debt
-3.71M15.00M
Net Debt Issuances and RepaymentsNet Debt Issuance
-1.56M-3.71M15.00M
Change in Capital Stock
Common Stock IssuedStock Issued
416.59M
Net Shares Issued and RepurchasedNet Shares Issued
416.59M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
416.59M
Other financing activities (as filed)
-0.03M
Cash from Financing ActivitiesCash from Financing
438.46M
Additional items
Exchange Rate EffectFX Effect
0.01M
Change in Cash
418.04M
Ending Cash Balance
537.61M
Free Cash FlowFCF
80.03M
Net Cash FlowNCF
418.03M
Interest Paid
0.01M
Income Taxes PaidTaxes Paid
-0.22M

Twist Bioscience Cash Flow Statement API

Pull Twist Bioscience's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TWST&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY